| Company Name: |
Biolab Reagents |
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
|
| | Quavonlimab Basic information |
| Product Name: | Quavonlimab | | Synonyms: | Quavonlimab;Research Grade Quavonlimab (DHD17206);Research Grade Quavonlimab;Quavonlimab (anti-CTLA-4) | | CAS: | 2254059-25-9 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Quavonlimab Structure]() |
| | Quavonlimab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Quavonlimab Usage And Synthesis |
| Uses | Quavonlimab (MK-1308) is a novel anti-CTLA-4 antibody[1]. | | References | [1] Perets R, et al. Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer. Ann Oncol. 2021;32(3):395-403. DOI:10.1016/j.annonc.2020.11.020 |
| | Quavonlimab Preparation Products And Raw materials |
|